Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 14/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 14/20 | 0.47 |
| ▸ | F2R | P25116 | 7/20 | 0.42 |
| ▸ | PADI1 | Q9ULC6 | 1/20 | 0.37 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7447082 | 0.97 | ITGB3 (0.48) | ITGB3ITGA2BF2RPADI1PADI4 | |
| SCHEMBL7451972 | 0.91 | ITGB3 (0.50) | ITGB3ITGA2BF2RPADI1PADI4 | |
| SCHEMBL7437047 | 0.86 | ITGB3 (0.38) | ITGB3ITGA2BF2RGAAALDH1A1 | |
| Hydrochloric Acid SCHEMBL7459720 | 0.85 | ITGB3 (0.47) | ITGB3ITGA2BF2RHTT | |
| Hydrochloric Acid SCHEMBL7445140 | 0.84 | ITGB3 (0.54) | ITGB3ITGA2BF2R | |
| SCHEMBL7439750 | 0.84 | ITGB3 (0.39) | ITGB3ITGA2BF2RGAAALDH1A1 | |
| SCHEMBL7439593 | 0.84 | ITGB3 (0.54) | ITGB3ITGA2BF2RHTTALDH1A1 | |
| Hydrochloric Acid SCHEMBL7459725 | 0.84 | ITGB3 (0.42) | ITGB3ITGA2BF2RHTTGAA | |
| SCHEMBL7447066 | 0.83 | ITGB3 (0.48) | ITGB3ITGA2BF2RHTTGAA | |
| SCHEMBL7447069 | 0.82 | ITGB3 (0.43) | ITGB3ITGA2BF2RHTTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384028-B1 | TREATMENT OF CARDIOVASCULAR DISORDERS, ANTICOAGULANTS AND VALVE REPLACEMENT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |